Actavis to Purchase Forest Labs in $25B Pharma Deal

Feb. 18 (Bloomberg) -- Bloomberg News’ Cristina Alesci reports on the $25 billion deal for Forest labs by Actavis to increase its focus on branded medicine on Bloomberg Television’s “Bloomberg Surveillance.”
Aussie Going the Wrong Way for the RBA
45:49 - Bloomberg’s Yvonne Man reports on the latest stories moving the currency market on "First Up." (Source: Bloomberg)
  • Greek Default Concern Sparks Selloff Across Debt Markets
  • HSBC Considers Return to HK as Revenue Misses
  • Spinoffs May Ease HSBC's Cost Problem, Schulte Says